DAVID STORM: Open Payments
NPI 1841767118 · HUNTSVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 10 payments from 9 companies in 2025. Trend: 2023 $184 · 2024 $77 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| GENZYME CORPORATION | 1 | $25 |
| The Binding Site Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: TZIELD, JOURNAVX, FABRAZYME, Freelite, AIRSUPRA, Dexcom G6 Transmitter, CAPLYTA, PURIFIED CORTROPHIN GEL.
Industry payments across AR — which companies pay providers there.
